Patientsville.com

Do You Have a Question about Your Health?

We will help You understand Your condition and Feel better! Ask Our Health Experts!

Private, Confidential and Discreet Type your question here

 letters left

PENTASA Safety Reports

Total PENTASA reports: 235.
PENTASA FDA safety alerts: No.
Reported deaths: 6    Reported hospitalizations: 150.
Take PENTASA Side Effects Survey or Share Your PENTASA Story. Read More Here.

Showing 1-75 of 235 Next >

Consumer or non-health professional from DENMARK reported PENTASA problem on July 01, 2005. Male patient, 42 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. PENTASA dosage: 2250 MG DAILY, ORAL. During the same period patient was treated with RABEPRAZOLE, TEPRENONE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on June 16, 2005. Male patient, 32 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: platelet count decreased, white blood cell count decreased. PENTASA dosage: 1500 MG DAILY, ORAL. During the same period patient was treated with AZATHIOPRINE. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on June 21, 2005. Male patient was diagnosed with inflammatory bowel disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pericarditis. PENTASA dosage: unknown. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Nov 09, 2005. Male patient, 36 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: myocarditis. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from DENMARK reported PENTASA problem on July 01, 2005. Male patient, 42 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. PENTASA dosage: 2250 MG DAILY, ORAL. During the same period patient was treated with RABEPRAZOLE, TEPRENONE, SULFASALAZINE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Health Professional from DENMARK on July 06, 2005. Female patient, 22 years of age, was diagnosed with inflammatory bowel disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with BUDESONIDE. Patient was hospitalized. Patient recovered.

Health Professional from DENMARK reported PENTASA problem on July 05, 2005. Female patient, 16 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: myocarditis. PENTASA dosage: unknown. During the same period patient was treated with BUDESONIDE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Health Professional from DENMARK on July 07, 2005. Female patient, 56 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia. PENTASA dosage: unknown. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on July 08, 2005. Male patient, 20 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pancreatitis acute. PENTASA dosage: 2250 MG DAILY, ORAL. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on July 15, 2005. Female patient, 19 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: myocarditis. PENTASA dosage: unknown. During the same period patient was treated with BUDESONIDE, MICROGYNON. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Aug 05, 2005. Female patient, 60 years of age, was diagnosed with inflammatory bowel disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: myocarditis. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Sept 21, 2005. Male patient, 24 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pericarditis. PENTASA dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Aug 25, 2005. Female patient, 20 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Jan 18, 2006. Female patient, 15 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pyrexia. PENTASA dosage: unknown. During the same period patient was treated with LANSOPRAZOLE, HYOSCINE HYT, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Feb 06, 2006. Female patient was diagnosed with colitis microscopic and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Feb 08, 2006. Female patient, 46 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: hepatitis. PENTASA dosage: unknown. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on May 29, 2006. Male patient, 20 years of age, was diagnosed with crohn's disease, gastritis and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: granulocytopenia. PENTASA dosage: unknown. During the same period patient was treated with FAMOTIDINE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Feb 22, 2006. Male patient, 46 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with IMURAN, SOLUPRED, AMINOSALICYLATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Apr 18, 2006. Male patient, 17 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with ALBUMIN TANNATE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Apr 14, 2006. Male patient, 44 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with SALAZOPYRIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Mar 30, 2006. Female patient, 20 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pericarditis. PENTASA dosage: 500 MG, 3X/DAY:TID, ORAL. During the same period patient was treated with HYDROXYZINE PAMOATE, CLOBETASONE BUTYRATE, CIPROFLOXACIN HYDROCHLORIDE, THEOPHYLLINE, AMBROXOL HYDROCHLORIDE. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Mar 30, 2006. Female patient, 25 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with MESALAZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Dec 12, 2005. Male patient, 37 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Dec 14, 2005. Male patient, child 9 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome, rash. PENTASA dosage: 500 MG, 3X/DAY:TID. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Dec 12, 2005. Male patient, 14 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial. PENTASA dosage: 750 MG, 3X/DAY:TID, ORAL. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Feb 27, 2006. Male patient, 22 years of age, was diagnosed with colitis ulcerative, anaemia, haematochezia and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased. PENTASA dosage: unknown. During the same period patient was treated with FESIN, CEFAMEZOL, PREDNISOLONE. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on July 07, 2006. Female patient, child 10 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with FERRIC OXIDE SACCHARATED. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Dec 28, 2005. Male patient, 27 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Dec 28, 2005. Male patient, 15 years of age, was diagnosed with inflammatory bowel disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with URSODIOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Jan 06, 2006. Male patient, 38 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from DENMARK reported PENTASA problem on Jan 06, 2006. Male patient, 29 years of age, was diagnosed with crohn's disease, sepsis and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. During the same period patient was treated with PIPERILLINE, NETROMYCIN, SMECTITE, PHLOROGLUCINOL, SMECTA, SPASFON, DEBRIDAT. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Feb 01, 2006. Male patient, 70 years of age, was diagnosed with behcet's syndrome and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. PENTASA dosage: unknown. During the same period patient was treated with AZELASTINE HYDROCHLORIDE, COLCHICUM JTL LIQ, NIZATIDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Sept 08, 2005. Male patient, 19 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. PENTASA dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Sept 08, 2005. Male patient, 64 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: white blood cell count decreased. PENTASA dosage: unknown. During the same period patient was treated with PREDNISOLONE, LANSOPRAZOLE, TEPRENONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Sept 30, 2005. Female patient, child 11 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Oct 11, 2005. Male patient, 40 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: 3000 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Oct 13, 2005. Male patient, 41 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pericarditis. PENTASA dosage: unknown. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Nov 25, 2005. Male patient, 15 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, nephritis interstitial, pancreatitis. PENTASA dosage: unknown. During the same period patient was treated with PREDNISOLONE PHOSPHATE, CEFTAZIDINE, FAMOTIDINE, TEPRENONE. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on Nov 04, 2005. Female patient, 16 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: 2250 MG DAILY, ORAL. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on Nov 23, 2005. Female patient, 18 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PENTASA problem on Dec 07, 2005. Male patient, 59 years of age, weighting 229.9 lb, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pancytopenia. PENTASA dosage: unknown. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on July 18, 2006. Female patient, 81 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, gastrointestinal infection, haemodialysis, infection in an immunocompromised host, inflammation, oedema peripheral, pseudomonal sepsis, respiratory distress, stomatitis. PENTASA dosage: 500 MG, 2X/DAY:BID, ORAL. During the same period patient was treated with OMEPRAZOLE, PREDNISOLONE, ALGINATE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient died on 06/16/2006.

Consumer or non-health professional from FRANCE reported PENTASA problem on July 25, 2006. Female patient, 29 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: congenital central nervous system anomaly. PENTASA dosage: unknown. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from DENMARK on July 27, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, liver disorder, lymphocyte stimulation test positive. PENTASA dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient recovered.

Consumer or non-health professional from DENMARK reported PENTASA problem on July 27, 2006. Female patient, 23 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: arthralgia, asthenia, chills, cytomegalovirus infection, hyperthermia, influenza like illness, myalgia, viral infection. PENTASA dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Male patient, 13 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pleurisy. PENTASA dosage: 1500 MG DAILY, ORAL. During the same period patient was treated with LACTOMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Aug 02, 2006. Female patient, 17 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative, disease recurrence, lung neoplasm, lymphocyte stimulation test positive, pulmonary cavitation, pulmonary mass, vertigo. PENTASA dosage: unknown. During the same period patient was treated with SULFASALAZINE, FERROUS CITRATE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from SPAIN on Aug 09, 2006. Female patient, 48 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: autoimmune hepatitis. PENTASA dosage: unknown. During the same period patient was treated with OMEPRAZOLE, AZATHIOPRINE, CORTICOSTEROIDS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported PENTASA problem on Sept 05, 2006. Female patient, 31 years of age, weighting 160.0 lb, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: angiopathy, headache, hyperaesthesia, pain, palpitations, pulmonary oedema, pyrexia, throat tightness. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from FRANCE on Aug 23, 2006. Female patient, 29 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: abortion induced, cerebellar hypoplasia. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported PENTASA problem on Aug 25, 2006. Male patient, 34 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: chest x-ray abnormal, eosinophilia, lung disorder, lymphocyte stimulation test positive, pulmonary eosinophilia. PENTASA dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, CIMETIDINE, TEPRENONE, ETIZOLAM, TIPEPIDINE HIBENZATE, THEOPHYLLINE, MINOCYCLINE HYDROCHLORIDE, CEFPODOXIME PROXETIL. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Aug 29, 2006. Male patient, 74 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PENTASA dosage: 2250 MG DAILY, ORAL. During the same period patient was treated with PREDNISOLONE PHOSPHATE, SULFASALAZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Sept 08, 2006. Female patient, 17 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, c-reactive protein increased, lung neoplasm, lymphocyte stimulation test positive, pulmonary cavitation, pulmonary mass, pyrexia, vertigo. PENTASA dosage: unknown. During the same period patient was treated with SALAZOPYRIN, FERROUS CITRATE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: pericarditis, pharyngolaryngeal pain, pleurisy. PENTASA dosage: 2250 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Sept 22, 2006. Male patient, 50 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, haematuria, histology abnormal, proteinuria. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: cough, pericardial effusion, pericarditis, pharyngolaryngeal pain, pleural effusion, pleurisy, pyrexia. PENTASA dosage: 750 MG, 3X/DAY; TID; ORAL. During the same period patient was treated with CEFAMEZIN, CEFDINIR. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Sept 27, 2006. Female patient, 17 years of age, was diagnosed with colitis ulcerative, abdominal pain upper and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, antineutrophil cytoplasmic antibody positive, colitis ulcerative, disease recurrence, pulmonary cavitation, pulmonary mass, pyrexia, vertigo. PENTASA dosage: unknown. During the same period patient was treated with SALAZOPYRIN, RABEPRAZOLE, FERROUS CITRATE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Sept 28, 2006. Male patient, 13 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: alveolitis allergic. PENTASA dosage: 500 MG, 3X/DAY:TID,ORAL. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Sept 27, 2006. Male patient, 16 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: cough, diarrhoea, eosinophilic pneumonia, pyrexia. PENTASA dosage: 500 MG, 3X/DAY:TID, ORAL. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Oct 05, 2006. Female patient, 29 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, hypokalaemia. PENTASA dosage: unknown. During the same period patient was treated with ASPARTATE POTASSIUM. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported PENTASA problem on Oct 05, 2006. Male patient, 81 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: alveolitis. PENTASA dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, LANSOPRAZOLE, MEBEVERINE, MOVICOL, PREDNISOLONE, SERETIDE. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Oct 05, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: abortion, abortion spontaneous, pregnancy. PENTASA dosage: 1000 MG DAILY, RECTAL. During the same period patient was treated with BETAMETHASONE, BETAMETASONE, RANITIDINE HYDROCHLORIDE, PREDNISOLONE, SULFASALAZINE. Patient recovered.

Health Professional from SWEDEN reported PENTASA problem on Oct 10, 2006. Female patient, 66 years of age, was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: renal failure. PENTASA dosage: unknown. During the same period patient was treated with MINERAL SALTS. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Nov 02, 2006. Male patient, 17 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: colitis ulcerative, disease recurrence, disseminated intravascular coagulation, haematoma, haemorrhage subcutaneous, laboratory test abnormal, skin graft, skin necrosis. PENTASA dosage: unknown. During the same period patient was treated with CEFDINIR, CEFAZOLIN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Oct 31, 2006. Male patient, 36 years of age, was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PENTASA dosage: 750 MG 3X'S DAILY, ORAL. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Nov 02, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. PENTASA dosage: 1000MG 4XS DAILY, ORAL. During the same period patient was treated with PROGRAF. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported PENTASA problem on Nov 03, 2006. Female patient was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: breech presentation, caesarean section, oligohydramnios. PENTASA dosage: 1000 MG DAILY, TRANSPLACENTAL. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Nov 30, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. PENTASA dosage: 1000 MG 3XS DAILY, ORAL; 1000 MG 4XS, DAILY, ORAL. During the same period patient was treated with PROGRAF. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Nov 30, 2006. Male patient, 21 years of age, was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: nephritis. PENTASA dosage: 3000 MG DAILY, ORAL. During the same period patient was treated with FAMOTIDINE. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Female patient, 23 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: chest pain, haemoglobin decreased, headache, heart rate increased, pleurisy, pneumonia, rhinorrhoea. PENTASA dosage: 500 MG 3XS DAILY; ORAL, 1000 MG 3XS DAILY,. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Dec 04, 2006. Male patient, 36 years of age, was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: acquired immunodeficiency syndrome, disseminated tuberculosis, hiv test positive, mucous stools, pneumonia viral. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from JAPAN on Dec 05, 2006. Male patient, 74 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. PENTASA dosage: 2250 MG DAILY, ORAL. During the same period patient was treated with PREDNISOLONE SUCCINATE, SULFASALAZINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported PENTASA problem on Dec 05, 2006. Male patient, 16 years of age, was diagnosed with crohn's disease and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, eosinophilic pneumonia. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

PENTASA problem was reported by a Consumer or non-health professional from NEW ZEALAND on Dec 19, 2006. Female patient, 31 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, cryptogenic organising pneumonia. PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported PENTASA problem on Dec 15, 2006. Male patient, 77 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, c-reactive protein increased, dyspnoea exertional, fibrin d dimer increased, intracardiac mass, intracardiac thrombus, pericardial effusion, platelet count decreased, treatment noncompliance. PENTASA dosage: 2000 MG DAILY, ORAL. During the same period patient was treated with RAMIPRIL, BISOPROLOL, AMLODIPINE BESYLATE, FUROSEMIDE, LANSOPRAZOLE, ALENDRONATE, ACETYLSLICYLATE LYSINE, PREDNISOLONE SULFOBENZOATE. Patient was hospitalized. Patient recovered.

Showing 1-75 of 235 Next >